HFMA’s virtual revenue cycle and price transparency series focuses on helping health systems re-engage consumers and improve financial performance
Beginning March 1, healthcare finance professionals can participate in several educational sessions and peer-to-peer discussions by enrolling in HFMA's virtual revenue cycle and price transparency workshop.
The implications of Amazon’s deal to buy One Medical: What healthcare providers should know
Amazon’s announced purchase of One Medical for nearly $4 billion should spur providers to fortify their primary care strategies.
News Briefs: Final rule for Medicare inpatient payments brings large rate increase
As published in hfm magazine, a monthly roundup of top news for healthcare finance professionals.
Financial and operational challenges still hamper hospitals 2.5 years into the pandemic
Even as much of society takes steps toward pre-pandemic normalcy, hospitals continue to struggle under the weight of the last two and a half years.
Final rule appears to give a boost to providers in No Surprises Act arbitration cases
A new final rule codifies updated criteria for deciding arbitration cases under the No Surprises Act, with providers potentially coming out ahead relative to last year’s interim final rule.
Landmark law to curb drug prices in Medicare has potential, but implementation will be key
Newly signed legislation gives Medicare authority to negotiate the prices of certain high-cost drugs with manufacturers.
Final rule for Medicare inpatient payments brings a big rate increase but falls short of what hospitals sought
The final rule for Medicare inpatient payments to acute care hospitals calls for a 4.3% increase, up by more than a percentage point from the proposed rule.
As revenue cycle challenges accumulate, a new survey suggests hospitals are taking a closer look at automation
For hospitals and health systems, survey results show that the ongoing labor crunch in revenue cycle operations has provided an impetus to expand process automation.
In an inflationary environment, pending Medicare payment updates don’t measure up
Consumer-focused inflation numbers aren’t as significant in healthcare as in other sectors, but prices are hampering hospitals and health systems.
Outpatient payment proposed rule: 340B drug payments to rise significantly in 2023 but will cut into the overall rate increase
Even before factoring in the impact of the 340B payment changes, hospital groups aren’t happy with the proposed payment update.